Anhui Huaheng Biotechnology Co., Ltd. (SHA:688639)
China · Delayed Price · Currency is CNY 17.00
-0.20 (-1.16%)
Aug 4, 2026, 3:00 PM CST
SHA:688639 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 4,240 | 8,125 | 7,340 | 19,834 | 16,829 | 13,959 | |
Market Cap Growth | -51.66% | 10.70% | -62.99% | 17.86% | 20.56% | - |
Enterprise Value | 6,141 | 9,710 | 8,935 | 20,261 | 16,421 | 13,519 |
Last Close Price | 17.00 | 32.39 | 31.78 | 84.49 | 71.46 | 59.23 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 34.14 | 61.36 | 38.73 | 44.17 | 52.59 | 82.97 |
Forward PE | 14.41 | 22.71 | 18.21 | 35.78 | 44.72 | 66.62 |
PS Ratio | 1.44 | 2.84 | 3.37 | 10.23 | 11.86 | 14.63 |
PB Ratio | 1.59 | 3.09 | 2.87 | 10.86 | 11.36 | 11.80 |
P/TBV Ratio | 1.67 | 3.26 | 3.02 | 11.39 | 11.96 | 12.25 |
P/OCF Ratio | 41.61 | 77.72 | 36.74 | 65.80 | 47.08 | 145.86 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 2.08 | 3.39 | 4.10 | 10.45 | 11.58 | 14.17 |
EV/EBITDA Ratio | 15.77 | 26.14 | 25.72 | 34.03 | 43.64 | 62.42 |
EV/EBIT Ratio | 39.49 | 61.96 | 42.80 | 40.80 | 51.79 | 79.96 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.89 | 0.78 | 0.60 | 0.68 | 0.05 | 0.02 |
Debt / EBITDA Ratio | 6.08 | 5.54 | 4.45 | 2.09 | 0.21 | 0.09 |
Net Debt / Equity Ratio | 0.72 | 0.67 | 0.44 | 0.49 | -0.18 | -0.38 |
Net Debt / EBITDA Ratio | 4.93 | 4.78 | 3.23 | 1.50 | -0.71 | -2.05 |
Net Debt / FCF Ratio | -3.14 | -3.33 | -1.55 | -0.92 | 2.72 | 5.23 |
Asset Turnover | 0.53 | 0.53 | 0.49 | 0.65 | 0.81 | 0.86 |
Inventory Turnover | 4.26 | 4.84 | 5.18 | 6.39 | 7.20 | 8.43 |
Quick Ratio | 0.60 | 0.53 | 0.51 | 0.41 | 1.77 | 3.82 |
Current Ratio | 1.21 | 1.09 | 0.84 | 0.63 | 2.22 | 4.66 |
Return on Equity (ROE) | 4.25% | 4.77% | 8.42% | 27.01% | 23.97% | 20.11% |
Return on Assets (ROA) | 1.74% | 1.82% | 2.91% | 10.35% | 11.32% | 9.53% |
Return on Invested Capital (ROIC) | 3.46% | 3.82% | 5.98% | 22.28% | 30.25% | 24.41% |
Return on Capital Employed (ROCE) | 3.40% | 3.50% | 6.20% | 21.70% | 19.40% | 13.10% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 2.91% | 1.63% | 2.58% | 2.26% | 1.90% | 1.21% |
FCF Yield | -14.41% | -6.55% | -9.86% | -4.88% | -0.59% | -0.61% |
Dividend Yield | 0.93% | 0.49% | 0.79% | 0.73% | 0.60% | 0.44% |
Payout Ratio | 93.56% | 83.69% | 96.78% | 24.25% | 18.83% | 22.32% |
Buyback Yield / Dilution | -6.31% | -8.10% | -0.88% | -0.72% | -9.33% | -22.57% |
Total Shareholder Return | -5.37% | -7.60% | -0.09% | 0.01% | -8.73% | -22.12% |